Chronic Lithium Treatment Affects Anxious Behaviors and theExpression of Serotonergic Genes in Midbrain Raphe Nuclei of Defeated Male Mice

Dmitry A. Smagin, И. Л. Коваленко, Anna G. Galyamina, Irina Belozertseva, N. V. Tamkovich, Konstantin O. Baranov, N. N. KudryavtsevaBiomedicines 2021 · DOI

TL;DR

This study investigates how chronic lithium chloride (LiCl) treatment affects anxiety-like behaviors and the expression of key serotonin-related genes in male mice subjected to chronic social defeat stress. The findings suggest that LiCl's effects are complex, exhibiting both anxiolytic and anxiogenic properties depending on the behavioral test and potentially the animal's individual sensitivity, while consistently upregulating serotonergic gene expression in the midbrain raphe nuclei.

What Problem Does This Paper Address?

Lithium is a well-established mood stabilizer used in treating bipolar disorder and other psychiatric conditions. However, its precise mechanisms of action, particularly concerning anxiety and depression, remain incompletely understood. While clinical responses to lithium are heterogeneous, with some patients being "good" or "poor" responders, the underlying reasons are not fully elucidated. This paper addresses the need to better understand how lithium influences anxiety-like states and the neurobiological pathways involved, specifically focusing on the serotonergic system in the midbrain raphe nuclei, which is crucial for mood regulation. The study aims to bridge the gap between behavioral observations and molecular changes induced by chronic lithium treatment in a model of chronic stress.

Methods

The researchers employed a multi-faceted approach combining behavioral testing and molecular analysis.

  • Chronic Social Defeat Stress Model: Male C57BL/6 mice were subjected to daily agonistic interactions for several days to induce an anxiety-like and depression-like state. This is a standard model for studying stress-related disorders.
  • Lithium Chloride (LiCl) Treatment: Following the initial stress period, mice were treated with either saline (control) or LiCl (100 mg/kg, intraperitoneally) daily for two weeks. This "preventive" treatment strategy aimed to assess LiCl's potential protective effects.
  • Behavioral Testing: A battery of tests was used to assess anxiety-like behaviors:
  • Partition Test: Evaluates social interaction and anxiety by observing a mouse's reaction to a conspecific behind a transparent partition.
  • Elevated Plus-Maze Test: A classic test for anxiety, measuring time spent and entries into open versus closed arms, indicating risk assessment and anxiety levels.
  • Social Interaction Test (with novel object): Assesses exploratory behavior and social interaction in a novel environment with an unfamiliar object (pencil holder) and then an unfamiliar conspecific.
  • Gene Expression Analysis (RT-PCR): Real-time quantitative polymerase chain reaction (RT-PCR) was used to measure the mRNA expression levels of key serotonergic genes in the midbrain raphe nuclei:
  • Tph2: Tryptophan hydroxylase 2, the rate-limiting enzyme in serotonin synthesis.
  • Slc6a4: Serotonin transporter, responsible for serotonin reuptake.
  • Htr1a and Htr5b: Genes encoding serotonin receptors.

Datasets

Not discussed in the paper. The study utilized laboratory mice as subjects and their behavioral and molecular responses as data.

Key Insights and Ideas

  • Context-Dependent LiCl Effects: The most striking insight is that LiCl's impact on anxiety is not uniform. It can be anxiolytic in one test (partition test) but anxiogenic in others (elevated plus-maze, social interaction test). This highlights the importance of the experimental context and the specific behavioral readout.
  • Individual Sensitivity Matters: The study identified that not all mice responded similarly to LiCl treatment. A subset of defeated mice (around 40%) showed pronounced anxiety-like behaviors after LiCl, suggesting individual differences in sensitivity that might be linked to baseline psycho-emotional states or genetic predispositions.
  • Serotonergic Gene Upregulation: Despite the varied behavioral outcomes, chronic LiCl treatment consistently led to an upregulation of Tph2, Slc6a4, Htr1a, and Htr5b gene expression in the midbrain raphe nuclei. This suggests a common molecular mechanism underlying LiCl's effects, potentially leading to increased serotonergic system activity.
  • Potential for Side Effects: The authors propose that the observed upregulation of serotonergic genes, while potentially beneficial for mood regulation, might paradoxically contribute to increased anxiety as a side effect, especially in certain contexts or individuals.

Key Results

  • Partition Test: Saline-treated defeated mice showed reduced behavioral activity (fewer approaches, less time near the partition, fewer rearings) compared to controls. LiCl treatment normalized these parameters, suggesting slight anxiolytic effects in this specific test.
  • Elevated Plus-Maze Test: LiCl treatment led to a general decrease in locomotor activity, which the authors interpret as a pro-depressive effect, potentially anxiogenic in this context.
  • Social Interaction Test: LiCl treatment induced strong anxiogenic effects in a subset of mice (LiCl+-treated losers), characterized by decreased approaches to a partner and increased time spent in corners.
  • Gene Expression: Chronic LiCl treatment significantly upregulated the expression of Tph2, Slc6a4, Htr1a, and Htr5b genes in the midbrain raphe nuclei of defeated mice compared to controls and saline-treated losers.

Limitations and Future Work

The authors acknowledge several limitations:

  • Gene Expression Complexity: The study focused on a few key serotonergic genes. They note that chronic social defeat stress affects the expression of many genes, and lithium's effects are likely mediated by a complex interplay of multiple genes, including those related to mitochondrial function, ribosomal activity, and neurotrophic factors.
  • Individual Differences: The observed heterogeneity in LiCl response warrants further investigation into the underlying neurobiological and genetic factors contributing to these differences.
  • Model Specificity: The findings are derived from a specific animal model of chronic stress and anxiety. Their direct translation to human clinical practice requires careful consideration.

Future work suggested includes:

  • Broader Genomic Studies: Investigating the expression of other candidate genes that are sensitive to lithium and involved in anxiety/depression to gain a more comprehensive understanding of lithium's neurogenomic mechanisms.
  • Combined Treatments: Exploring the potential benefits of co-administering lithium with anxiolytics to mitigate potential side effects and enhance therapeutic outcomes.
  • Translational Research: Further research is needed to bridge the gap between these animal findings and human clinical observations, particularly regarding individual responses to lithium.

Summary updated

Abstract

There is experimental evidence that chronic social defeat stress is accompanied by the development of an anxiety, development of a depression-like state, and downregulation of serotonergic genes in midbrain raphe nuclei of male mice. Our study was aimed at investigating the effects of chronic lithium chloride (LiCl) administration on anxiety behavior and the expression of serotonergic genes in midbrain raphe nuclei of the affected mice. A pronounced anxiety-like state in male mice was induced by chronic social defeat stress in daily agonistic interactions. After 6 days of this stress, defeated mice were chronically treated with saline or LiCl (100 mg/kg, i.p., 2 weeks) during the continuing agonistic interactions. Anxiety was assessed by behavioral tests. RT-PCR was used to determine <i>Tph2, Htr1a, Htr5b,</i> and <i>Slc6a4</i> mRNA expression. The results revealed anxiolytic-like effects of LiCl on social communication in the partition test and anxiogenic-like effects in both elevated plus-maze and social interaction tests. Chronic LiCl treatment upregulated serotonergic genes in midbrain raphe nuclei. Thus, LiCl effects depend on the treatment mode, psycho-emotional state of the animal, and experimental context (tests). It is assumed that increased expression of serotonergic genes is accompanied by serotonergic system activation and, as a side effect, by higher anxiety.
BibTeX
@inproceedings{smagin2021chronic,
  author = {Dmitry A. Smagin and И. Л. Коваленко and Anna G. Galyamina and Irina Belozertseva and N. V. Tamkovich and Konstantin O. Baranov and N. N. Kudryavtseva},
  title = {{Chronic Lithium Treatment Affects Anxious Behaviors and theExpression of Serotonergic Genes in Midbrain Raphe Nuclei of Defeated Male Mice}},
  booktitle = {Biomedicines},
  year = {2021},
  doi = {10.3390/biomedicines9101293},
}
Figure